Efficacy of agomelatine for anxiety symptoms in adult patients with major depressive disorder

被引：0
|
作者：
Stein, D. [1 ]
Chimits, D. [2 ]
Picarel-Blanchot, F. [3 ]
Khoo, J. P. [4 ]
机构：
[1] Groote Schuur Hosp, J Block Anzio Rd Observ, ZA-7925 Cape Town, South Africa
[2] Inst Rech Servier, CentEX Methodol & Valorisat Data, F-92284 Suresnes, France
[3] Servier Med Affairs Internal Med & Neuropsychiat, Suresnes, France
[4] Toowong Specialist Clin, Level 2,54 Jephson St, Toowong, Qld 4066, Australia
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2020年 / 40卷
关键词：
D O I：
10.1016/j.euroneuro.2020.09.081
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.095
引用
收藏
页码：S59 / S60
页数：2
相关论文
共 50 条
  • [31] Anxiety Symptoms in Patients with Major Depressive Disorder: Commentary on Prevalence and Clinical Implications
    Malcolm Hopwood
    [J]. Neurology and Therapy, 2023, 12 : 5 - 12
  • [32] Anxiety Symptoms in Patients with Major Depressive Disorder: Commentary on Prevalence and Clinical Implications
    Hopwood, Malcolm
    [J]. NEUROLOGY AND THERAPY, 2023, 12 (SUPPL 1) : 5 - 12
  • [33] A meta-analysis of the efficacy of vortioxetine in patients with major depressive disorder (MDD) and high levels of anxiety symptoms
    Baldwin, David S.
    Florea, Ioana
    Jacobsen, Paula L.
    Zhong, Wei
    Nomikos, George G.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2016, 206 : 140 - 150
  • [34] Influence of comorbid anxiety symptoms on cognitive deficits in patients with major depressive disorder
    Liu Jin
    Dong Qiangli
    Lu Xiaowen
    Sun Jinrong
    Zhang Liang
    Wang Mi
    Liu Bangshan
    Ju Yumeng
    Wan Ping
    Guo Hua
    Zhao Futao
    Zhang Xiangyang
    Zhang Yan
    Li Lingjiang
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2020, 260 : 91 - 96
  • [35] Efficacy of venlafaxine extended-release compared with placebo in major depressive disorder patients by severity of anxiety symptoms
    Lyndon, G.
    Prieto, R.
    Wajsbrot, D.
    Allgulander, C.
    Bandelow, B.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S807 - S808
  • [36] Major Depressive Disorder, sleep EEG and agomelatine
    Quera Salva, M.
    Vanier, B.
    Laredo, J.
    Moulin, C.
    Chapotot, F.
    Lofaso, F.
    Christian, G.
    [J]. SLEEP, 2006, 29 : A325 - A326
  • [37] Symptoms of social anxiety disorder and major depressive disorder: A network perspective
    Langer, Julia K.
    Tonge, Natasha A.
    Piccirillo, Marilyn
    Rodebaugh, Thomas L.
    Thompson, Renee J.
    Gotlib, Ian H.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2019, 243 : 531 - 538
  • [38] Discontinuation symptoms in social anxiety disorder, general anxiety disorder, and major depressive disorder.
    Montgomery, SA
    Baldwin, D
    Nil, R
    Lader, M
    [J]. NORDIC JOURNAL OF PSYCHIATRY, 2005, 59 (05) : 416 - 416
  • [39] Clinical Studies on the Efficacy of Agomelatine on Depressive Symptoms
    Goodwin, Guy M.
    [J]. CNS DRUGS, 2009, 23 : 35 - 39
  • [40] Clinical Studies on the Efficacy of Agomelatine on Depressive Symptoms
    Guy M. Goodwin
    [J]. CNS Drugs, 2009, 23 : 35 - 39
12345